Related Experiment Videos
Selective damage to carcinoma mitochondria by the rhodacyanine MKT-077
J S Modica-Napolitano1, K Koya, E Weisberg
1Tufts University, Department of Biology, Medford, Massachusetts 02155, USA.
Abstract:
We investigated the mitochondrial toxicity of the lipophilic cation, MKT-077, and the role of mitochondria in selective malignant cell killing by this compound by examining the effect of MKT-077 on mitochondrial structure and function in treated cells and in isolated organelles. Results of this study demonstrate changes in mitochondrial ultrastructure that are induced by MKT-077 treatment in carcinoma cells but not in similarly treated normal epithelial cells. In addition, MKT-077 was found to inhibit respiratory activity in isolated intact mitochondria and electron transport activity in freeze-thawed mitochondrial membrane fragments in a dose-dependent manner. The concentration of MKT-077 necessary to obtain half-maximal inhibition of ADP-stimulated respiration was approximately 4-fold greater in mitochondria isolated from cells of the normal epithelial cell line, CV-1 (15 micrograms MKT-077/mg protein), as compared to the human colon carcinoma cell line, CX-1 (4 micrograms MKT-077/mg protein). Further, the data show a selective loss of mitochondrial DNA in CX-1 and CRL1420 cells (carcinoma) but not CV-1 cells (normal epithelial) treated with 3 microgram/ml MKT-077 for up to 3 days. Under the same conditions, nuclear DNA was unaffected in all three cell lines. The sensitivity of the cell lines tested to mitochondrial damage by MKT-077 correlates well with their sensitivity to cytotoxicity by MKT-077. These results demonstrate selective mitochondrial damage by MKT-077 at the cellular, biochemical, and molecular levels and suggest that selective effects on mitochondrial structure and function may provide a basis for the selective malignant cell killing exhibited by this compound.
Insights
The lipophilic cation MKT-077 selectively damages mitochondria in cancer cells, not normal cells. This mitochondrial toxicity, affecting structure, function, and DNA, underlies MKT-077
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Mitochondria play crucial roles in cellular energy production and apoptosis.
- Selective cancer therapies aim to target malignant cells while sparing normal tissues.
- MKT-077 is a lipophilic cation investigated for its potential anti-cancer properties.
Purpose of the Study:
- To investigate the mitochondrial toxicity of MKT-077.
- To determine the role of mitochondria in the selective killing of malignant cells by MKT-077.
- To examine the effects of MKT-077 on mitochondrial structure and function.
Main Methods:
- Treatment of carcinoma and normal epithelial cells with MKT-077.
- Examination of mitochondrial ultrastructure using electron microscopy.
- Assessment of respiratory and electron transport activities in isolated mitochondria.
- Analysis of mitochondrial and nuclear DNA integrity.
- Cytotoxicity assays to determine cell sensitivity.
Main Results:
- MKT-077 induced ultrastructural changes in mitochondria of carcinoma cells but not normal epithelial cells.
- MKT-077 inhibited mitochondrial respiration and electron transport in a dose-dependent manner.
- Mitochondria from carcinoma cells (CX-1) were more sensitive to MKT-077 inhibition than those from normal cells (CV-1).
- Selective loss of mitochondrial DNA was observed in MKT-077-treated carcinoma cells, while nuclear DNA remained unaffected.
- Cellular sensitivity to MKT-077-induced mitochondrial damage correlated with cytotoxicity.
Conclusions:
- MKT-077 causes selective mitochondrial damage at cellular, biochemical, and molecular levels.
- Mitochondrial damage by MKT-077 contributes to its selective killing of malignant cells.
- Targeting mitochondrial structure and function represents a potential strategy for cancer therapy with MKT-077.